Cure of cryptococcal infection during continued immunosuppressive therapy

Area of Science:

• Medical Mycology
• Nephrology
• Immunosuppression

Background:

• Cryptococcus neoformans is a major opportunistic fungal pathogen, particularly affecting immunocompromised individuals.
• Renal transplant recipients on prednisone are at high risk for cryptococcosis, often with a poor prognosis.
• Managing cryptococcosis in these patients presents a dilemma: stopping prednisone risks graft loss, while continuing it may worsen the fungal infection.

Purpose of the Study:

• To evaluate the safety and efficacy of continuing maintenance immunosuppression in renal transplant recipients with cryptococcal infections.
• To determine if combined antifungal therapy and continued immunosuppression can lead to successful cryptococcosis eradication without compromising allograft function.

Main Methods:

• Retrospective analysis of 13 renal transplant patients diagnosed with cryptococcosis.
• Careful continuation of maintenance immunosuppressive therapy (prednisone) in 11 patients during antifungal treatment.
• Monitoring for graft function and fungal clearance.

Main Results:

• Successful eradication of Cryptococcus neoformans was achieved in patients who continued maintenance immunosuppression.
• Allograft function was preserved in the majority of patients receiving combined therapy.
• No significant increase in graft loss or adverse events related to continued immunosuppression was observed.

Conclusions:

• Maintenance immunosuppressive therapy can be safely continued in renal transplant recipients during antifungal treatment for cryptococcosis.
• This approach improves the prognosis for renal transplant patients with cryptococcal infections.
• Optimizing treatment strategies can preserve both the transplanted kidney and patient survival.